Trial
NCT03532035
Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Jazz Pharmaceuticals
Collaborators
—
Condition
Adenovirus
Intervention
Brincidofovir
Why stopped
terminated due to low enrollment rate
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-07-21